Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) EBIT Margin: 2009-2024

Historic EBIT Margin for Ironwood Pharmaceuticals (IRWD) over the last 16 years, with Dec 2024 value amounting to 26.50%.

  • Ironwood Pharmaceuticals' EBIT Margin rose 3385.00% to 61.84% in Q3 2025 from the same period last year, while for Sep 2025 it was 36.34%, marking a year-over-year increase of 1012.00%. This contributed to the annual value of 26.50% for FY2024, which is 24004.00% up from last year.
  • According to the latest figures from FY2024, Ironwood Pharmaceuticals' EBIT Margin is 26.50%, which was up 112.41% from -213.54% recorded in FY2023.
  • Ironwood Pharmaceuticals' EBIT Margin's 5-year high stood at 60.97% during FY2022, with a 5-year trough of -213.54% in FY2023.
  • Moreover, its 3-year median value for EBIT Margin was 26.50% (2024), whereas its average is -42.02%.
  • Per our database at Business Quant, Ironwood Pharmaceuticals' EBIT Margin tumbled by 27,451bps in 2023 and then skyrocketed by 24,004bps in 2024.
  • Over the past 5 years, Ironwood Pharmaceuticals' EBIT Margin (Yearly) stood at 36.70% in 2020, then soared by 1,944bps to 56.13% in 2021, then skyrocketed by 483bps to 60.97% in 2022, then crashed by 27,451bps to -213.54% in 2023, then surged by 24,004bps to 26.50% in 2024.